acarizax tablet
alk-abello a/s - dermatophagoides pteronyssinus; dermatophagoides farinae - tablet - 6unit; 6unit - dermatophagoides pteronyssinus 6unit; dermatophagoides farinae 6unit - allergenic extracts
acarizax (american house dust mite extract and european house dust mite extract) sublingual tablet
seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.
acarizax
seqirus (nz) ltd - dermatophagoides farinae allergen extract 6 sq-hdm; dermatophagoides pteronyssinus allergen extract 6 sq-hdm - sublingual tablet - 12 sq-hdm - active: dermatophagoides farinae allergen extract 6 sq-hdm dermatophagoides pteronyssinus allergen extract 6 sq-hdm excipient: gelatin mannitol sodium hydroxide - acarizax is indicated for the treatment of adults diagnosed with: - house dust mite (hdm) allergic rhinitis (ar) not well controlled despite use of symptom relieving medication or - hdm allergic asthma (aa) not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis. patients' asthma status should be carefully evaluated before the initiation of treatment.
acarizax
trupharm marketing 1985 ltd. - dermatophagoides farina; dermatophagoides pteronyssinus - tablets - dermatophagoides pteronyssinus 6 sq-hdm; dermatophagoides farina 6 sq-hdm - house dust - acarizax is indicated in adult patients (18-65 years) diagnosed by clinical history and a positive test of house dust mite sensitisation (skin prick test and/or specific ige) with at least one of the following conditions: • persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication • house dust mite allergic asthma not well controlled by inhaled corticosteroids and associated with mild to severe house dust mite allergic rhinitis. patients' asthma status should be carefully evaluated before the initiation of treatment.acarizax is indicated in adolescents (12-17 years) diagnosed by clinical history and a positive test of house dust mite sensitisation (skin prick test and/or specific ige) with persistent moderate to severe house dust mite allergic rhinitis despite use of symptom-relieving medication.
acarizax 12 sq-hdm lyophilisat zum einnehmen
acarizax 12 sq-hdm sublingual lyophilisate
alk-abello a/s - dermatophagoides farinae extract; dermatophagoides pteronyssinus extract - sublingual lyophilisate - 12 - house dust mites
probiotico capsulas nutrigar
laboratorios rigar s.a. - fructooligosacaridos - fructooligosacaridos....100 mg / bacillus coagulans....48 mg
viusid biotic
catalysis, s.l. - fructooligosacaridos - fructooligosacaridos....600.78 mg / l-glicina....164 mg / sulfato de glucosamina cloruro potÁsico....326.34 mg / Ácido fÓlico (Ácido pteroilmonoglutÁmico)....32 mcg / Ácido pantotÉnico (d-pantotenato cÁlcico)....0.9 mg / l-arginina....328.01 mg / extracto de alfalfa (medicago sativa l.)....20 mg / sulfato de zinc....2.5 mg / vitamina c (Ácido l-ascÓrbico)....9.9 mg / glicirrinato monoamÓnico (glycyrrhiza glabra l.)....16.17 mg / glutamina....492.5 mg / vitamina b-12 cianocobalamina....0.146 mcg / mezcla de bacterias ....500 mg
acarizax 12 sq-hdm 30 liofilitzats orals
acarizax 12 sq-hdm 90 liofilitzats orals